Status:
COMPLETED
Feasibility of Nurse-led Retinal Imaging for Retinopathy of Prematurity Screening Employing the Optos California
Lead Sponsor:
University of Nottingham
Collaborating Sponsors:
University Hospitals of Derby and Burton NHS Foundation Trust
Conditions:
Retinopathy of Prematurity
Eligibility:
All Genders
32-1 years
Phase:
NA
Brief Summary
Retinopathy of prematurity (ROP) is a preventable cause of blindness in babies who are born early i.e. premature. Internationally, there is a shortage of skilled ophthalmologists willing and able to s...
Detailed Description
Retinopathy of Prematurity (ROP) is the major cause of blindness in babies who are born early i.e. premature (defined as those born at less than 37 weeks' gestation). All premature infants are at risk...
Eligibility Criteria
Inclusion
- Infants (upper age limit 1 years old) eligible for routine ROP screening as part UK ROP screening guidelines (any infant born at or before 32 weeks' gestation and / or weigh 1500 grams or less).
- Infants with parents/legal guardians who can give written informed consent.
Exclusion
- Infants not eligible for routine ROP screening under UK ROP screening guidelines.
- Infants who are deemed not well enough by the attending consultant neonatologist for retinal examination or retinal imaging.
- Any premature infant with media opacities that prevents adequate visualisation of the retina.
- Inability of the parents to give written, informed consent.
Key Trial Info
Start Date :
May 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2023
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT06063863
Start Date
May 10 2021
End Date
August 1 2023
Last Update
October 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals of Derby and Burton
Derby, Derbyshire, United Kingdom, DE22 3DT